BioIndustry Association - 2021 Half Year Review
July 2021
Given the remarkable outperformance of the UK listed Biotech sector during 2020; it is notable that much of this outperformance has been maintained through 2021 so far. Neither the pace of share price increases, nor the scale and frequency of capital raising activity, were ever likely to replicate 2020 but we have not yet witnessed any significant reversals.
Download